Drug intelligence / Profile preview

dofetilide

Development stage
Approved
Lead developer
Pfizer
Modality
Small Molecules
Administration
Oral
01

Overview

Dofetilide is a class III antiarrhythmic agent used to treat irregular heartbeats, specifically atrial fibrillation and atrial flutter. It works by selectively blocking the rapid component of the delayed rectifier outward potassium current (IKr), which increases the refractory period of atrial tissue and helps restore and maintain normal sinus rhythm. Dofetilide does not affect conduction velocity or resting membrane potential. The drug is available as an oral capsule and requires close monitoring during initiation due to its potential to cause serious arrhythmias, including QT prolongation and torsade de pointes. Dofetilide is marketed under the brand name Tikosyn in the United States.

Brand names
Tikosyn
Other names
Dofetilide IVIntravenous dofetilide
02

Targets

KCNH2 (Voltage-gated potassium channel subfamily H member 2)

Beyond the preview

Go deeper on dofetilide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on dofetilide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call